Pacira BioSciences, Inc.
PCRX
$36.31-0.11%
End of day · as of Oct 13, 2026, 8:00 PM ET
Mkt cap
$890.84M
EV/Sales
1.52
P/E ratio
N/A
FY2025 Revenue
$726.41M
EPS (H1 2026)
$0.19
Gross Margin (FY2025)
79.39%
Profit Margin (FY2025)
0.97%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PCRX revenue for 2025-12-31 was $726.4M. Net income was $7.0M. Revenue was up 3.6% from 2024-12-31 to 2025-12-31. PCRX currently screens at market cap $890.8M.
Use this PCRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PCRX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Pacira BioSciences, Inc. (PCRX) revenue for Dec 31, 2025 was $726.4M. Net income was $7.0M. Statements: https://lician.com/financials/pcrx
Pacira BioSciences, Inc. (PCRX) market capitalization is $890.8M on the latest cached snapshot.
Pacira BioSciences, Inc. (PCRX) cached previous close $36.35; day range $36.31 – $36.38; volume 2,221,883. Session quote: https://lician.com/quote/pcrx
Pacira BioSciences, Inc. (PCRX) latest cached earnings event is "PCRX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings